- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
670
Companies which are more than 50% undervalued based on analyst price target.
670 companies
Cadrenal Therapeutics
Market Cap: US$25.6m
Operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions.
CVKD
US$13.25
7D
2.2%
1Y
69.2%
Enlivex Therapeutics
Market Cap: US$25.5m
Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.
ENLV
US$1.06
7D
1.0%
1Y
-16.5%
SenesTech
Market Cap: US$25.5m
Engages in the development and commercialization of a technology for managing animal pest populations through fertility control.
SNES
US$5.03
7D
1.8%
1Y
64.3%
Boundless Bio
Market Cap: US$25.3m
A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).
BOLD
US$1.15
7D
2.7%
1Y
-63.3%
FibroBiologics
Market Cap: US$24.9m
Operates as a cell therapy, regenerative medicine company.
FBLG
US$0.57
7D
-2.7%
1Y
-72.5%
Rallybio
Market Cap: US$24.5m
A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.
RLYB
US$0.61
7D
13.4%
1Y
-44.7%
Isofol Medical
Market Cap: SEK 229.2m
Operates as a clinical stage biotech company.
ISOFOL
SEK 0.82
7D
-3.4%
1Y
-70.3%
IRLAB Therapeutics
Market Cap: SEK 228.9m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 2.70
7D
-11.9%
1Y
-81.1%
Akari Therapeutics
Market Cap: US$23.8m
An oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins.
AKTX
US$0.82
7D
7.7%
1Y
-75.3%
SAB Biotherapeutics
Market Cap: US$23.5m
A clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders.
SABS
US$2.27
7D
9.1%
1Y
-20.1%
Medivir
Market Cap: SEK 214.5m
A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.
MVIR
SEK 1.91
7D
-1.9%
1Y
-36.1%
Microbix Biosystems
Market Cap: CA$31.4m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.23
7D
0%
1Y
-37.3%
Neuphoria Therapeutics
Market Cap: US$22.4m
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.
NEUP
US$11.89
7D
4.9%
1Y
n/a
ProMIS Neurosciences
Market Cap: US$22.3m
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.
PMN
US$0.43
7D
-20.4%
1Y
-66.9%
Passage Bio
Market Cap: US$22.3m
A genetic medicines company, develops gene therapies for central nervous system diseases.
PASG
US$7.18
7D
0.7%
1Y
-49.0%
Allarity Therapeutics
Market Cap: US$22.1m
A clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs.
ALLR
US$1.97
7D
27.9%
1Y
-60.3%
Solvonis Therapeutics
Market Cap: UK£16.3m
A clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders.
SVNS
UK£0.0025
7D
-7.6%
1Y
51.6%
Active Biotech
Market Cap: SEK 204.2m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.17
7D
-9.3%
1Y
-56.2%
Curis
Market Cap: US$21.4m
A biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.
CRIS
US$1.68
7D
0.6%
1Y
-66.3%
Advicenne
Market Cap: €18.1m
A specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.
ALDVI
€1.28
7D
1.9%
1Y
17.4%
Harvard Bioscience
Market Cap: US$20.8m
Develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally.
HBIO
US$0.48
7D
-3.4%
1Y
-82.4%
Annexin Pharmaceuticals
Market Cap: SEK 194.8m
A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.
ANNX
SEK 27.60
7D
10.4%
1Y
-46.1%
Cingulate
Market Cap: US$20.5m
A biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.
CING
US$3.90
7D
-2.3%
1Y
-34.1%
Q32 Bio
Market Cap: US$20.2m
A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction.
QTTB
US$1.67
7D
-2.3%
1Y
-96.1%
Aytu BioPharma
Market Cap: US$20.2m
A pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.
AYTU
US$2.25
7D
-4.3%
1Y
-5.9%
NFL Biosciences
Market Cap: €17.2m
A biotechnology company, engages in the development of botanical drugs in France.
ALNFL
€1.36
7D
-5.6%
1Y
-37.8%
Sonnet BioTherapeutics Holdings
Market Cap: US$19.8m
A biotechnology company, owns a platform for biologic medicines of single or bifunctional action.
SONN
US$2.85
7D
-12.3%
1Y
-59.1%
Abpro Holdings
Market Cap: US$19.6m
A biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology.
ABP
US$0.21
7D
-12.3%
1Y
-98.1%
Citius Pharmaceuticals
Market Cap: US$19.6m
A biopharmaceutical company, focuses on the development and commercialization of critical care products.
CTXR
US$1.23
7D
-7.5%
1Y
-90.7%
Lexaria Bioscience
Market Cap: US$18.9m
Operates as a biotechnology company.
LEXX
US$1.03
7D
17.0%
1Y
-67.1%
GeoVax Labs
Market Cap: US$18.7m
A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.
GOVX
US$0.70
7D
-6.4%
1Y
-79.6%
Biovica International
Market Cap: SEK 174.0m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.63
7D
-5.7%
1Y
-75.7%
Lisata Therapeutics
Market Cap: US$18.5m
A clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.
LSTA
US$2.17
7D
-6.5%
1Y
-30.0%
Edesa Biotech
Market Cap: US$17.8m
A clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.
EDSA
US$2.53
7D
9.1%
1Y
-42.1%
Hoth Therapeutics
Market Cap: US$17.8m
A clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs.
HOTH
US$1.33
7D
14.7%
1Y
25.5%
Klaria Pharma Holding AB (publ.)
Market Cap: SEK 162.3m
A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.
KLAR
SEK 0.66
7D
25.5%
1Y
34.7%